We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HKD:NYSEAMTD Digital Inc. Analysis

Data as of 2026-05-19 - not real-time

$1.66

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

AMTD Digital is trading at $1.66, just below its 20‑day SMA of $1.70 and marginally under the 50‑day SMA of $1.67, while still above the 200‑day SMA of $1.63, indicating a short‑term pull‑back within a longer‑term uptrend. The RSI sits at 48, suggesting neutral momentum, but the MACD histogram is negative and the MACD line is below its signal, pointing to bearish pressure. Volatility is elevated at 42.6% over the past 30 days and beta is modestly above 1 (≈1.12), implying the stock moves more than the market and could swing sharply. Technical signals therefore warn of downside risk near the $1.60 support level.
Fundamentally, the company posts impressive margins – 75.6% gross, 60.4% operating and 40.2% net – and a solid ROE of 25%, yet free cash flow is deeply negative (‑$194 M) despite positive operating cash flow, highlighting cash‑burn concerns. The trailing P/E of 9.2 is far below the industry average of 38.3, suggesting a value tilt, but the DCF‑derived fair value of $0.48 is dramatically lower than the market price, flagging potential overvaluation. The recent announcement of a dividend‑in‑kind plan from AMTD IDEA Group could provide a catalyst, though no cash dividend is currently sustainable. Overall, the stock balances strong profitability against high cash‑flow risk and elevated market volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price testing $1.60 support with bearish MACD
  • High 30‑day volatility and beta above 1
  • Uncertainty around timing of dividend‑in‑kind distribution

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued P/E relative to industry peers
  • Strong profitability margins and ROE
  • Potential upside from upcoming dividend‑in‑kind plan

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Sustained negative free cash flow
  • Regulatory exposure in China and other markets
  • DCF fair value far below current market price

Key Metrics & Analysis

Financial Health

Revenue Growth340.90%
Profit Margin40.20%
P/E Ratio9.2
ROE25.44%
ROA7.38%
Debt/Equity43.15
P/B Ratio2.0
Op. Cash Flow$14.4M
Free Cash Flow$-193962000
Industry P/E38.3

Technical Analysis

TrendBullish
RSI47.6
Support$1.60
Resistance$1.86
MA 20$1.70
MA 50$1.66
MA 200$1.63
MACDBearish
VolumeStable
Fear & Greed Index89.59

Valuation

Fair Value$0.48
GradeFair
TypeBlend

Risk Assessment

Beta1.12
Volatility42.59%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.